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ttp://dx.doi.org/10.1016/j.ajpath.2012.09.014Arginine vasopressin (AVP) affects kidney function via vasopressin V2 receptors that are linked to
activation of adenylyl cyclase (AC) and an increase in cyclic adenosine monophosphate formation.
AVP/cyclic adenosine monophosphate enhance the phosphorylation of the Na-K-2Cl cotransporter
(NKCC2) at serine residue 126 (pS126 NKCC2) and of the Na-Cl cotransporter (NCC) at threonine 58
(pT58 NCC). The isoform(s) of AC involved in these responses, however, were unknown. Phosphory-
lation of S126 NKCC2 and T58 NCC, induced by the V2 receptor agonist (1-desamino-8-D-arginine
vasopressin) in wild-type mice, is lacking in knockout mice for AC isoform 6 (AC6). With regard to
NKCC2 phosphorylation, the stimulatory effect of 1-desamino-8-D-AVP and the defect in AC6/ mice
seem to be restricted to the medullary portion of the thick ascending limb. AC6 is also a stimulator of
total renal NKCC2 protein abundance in medullary and cortical thick ascending limb. Consequently,
mice lacking AC6 have lower NKCC2 expression and a mild Bartter syndrome-like phenotype, including
lower plasma concentrations of Kþ and Hþ and compensatory upregulation of NCC. Increased AC6-
independent phosphorylation of NKCC2 at S126 might help to stabilize NKCC2 activity in the
absence of AC6. Renal AC6 determines total NKCC2 expression and mediates vasopressin-induced
NKCC2/NCC phosphorylation. These regulatory mechanisms, which are defective in AC knockout
mice, are likely responsible for the observed mild Bartter syndrome. (Am J Pathol 2013, 182: 96e106;
http://dx.doi.org/10.1016/j.ajpath.2012.09.014)Supported in part by NIH grants (R01DK56248, R01HL94728, and
R01DK28602 toV.V. and 5P01HL066941 toH.K.H.) theO’Brien Center for
acute kidney injury research (P30DK079337 toV.V. and T.R.), the American
Heart Association (GRNT3440038 to V.V., 11GRNT7610059 to T.T., and
10SDG2610034 to T.R.), the American Society of Nephrology (Carl W.
Gottschalk Research Scholar Grant to T.R.), a Veterans Affairs Merit Award
(H.K.H.), and theLundbeckFoundation,DanishResearchCouncil, andNovo
Nordisk Foundation (R.A.F.)
R.A.F. and V.V. contributed equally to this work.The antidiuretic hormone arginine-vasopressin (AVP) is the
primary regulator of water reabsorption in the renal collecting
duct and is critically involved in the regulation of water
balance and maintenance of plasma osmolality.1 AVP acti-
vates the Gs protein-coupled vasopressin V2 receptor (V2R)
to stimulate adenylyl cyclase (AC), and thus the synthesis of
cyclic adenosine monophosphate (cAMP).2 Nine different
membrane-bound isoforms of AC have been identiﬁed
(AC1eAC9).3 We previously showed that adenylyl cyclase
isoform 6 (AC6) determines AVP-induced cAMP formation,
aquaporin 2 phosphorylation and trafﬁcking in the inner
medulla, and that mice lacking AC6 have nephrogenic dia-
betes insipidus.4 On the whole kidney level, AC6/ mice
were found to have severely impaired cAMP formation when
stimulated with forskolin, an unspeciﬁc AC activator,5stigative Pathology.
.indicating a possible role of AC6-derived cAMP beyond
the inner medullary collecting duct. In comparison to AVP
activation of water transport, less is known regarding the role
of AVP in the phosphorylation and membrane abundance of
other renal epithelial transporters, including the role of
speciﬁc AC isoforms in these effects.
The Role of AC6 in NKCC2/NCC RegulationThe Na-K-2Cl co-transporter 2 (NKCC2) is expressed
in the medullary thick ascending limb (mTAL) and the
cortical thick ascending limb (cTAL) of the loop of
Henle, whereas the Na-Cl co-transporter (NCC) is local-
ized to the distal convoluted tubule (DCT). Inactivating
mutations in both NKCC2 and NCC are of clinical
relevance and cause Bartter and Gitelman syndromes,6
respectively. Both segments express the V2R as shown
by immunohistochemistry, mRNA expression, and protein
abundance.7e11 Moreover, AVP has been shown to
stimulate NKCC2 and NCC activity,12e14 including
micropuncture studies in rats in which the V2R agonist 1-
desamino-8-D-arginine vasopressin (dDAVP) stimulated
NaCl transport in both thick ascending limb (TAL)15 and
DCT.16
Gimenez and Forbush17 demonstrated that short-term
activation of NKCC2 by dDAVP involves NKCC2 phos-
phorylation in the mouse kidney. The use of an antibody
(R5) that targets double phosphorylated NKCC2 at threo-
nine residues 96 and 101 (T96 and T101), indicated a 55%
increase of NKCC2 membrane abundance on dDAVP
stimulation. More recently, Gunaratne et al18 demonstrated
that T96, but not T101, of NKCC2 is phosphorylated by
dDAVP stimulation. Extensive phosphoproteomic proﬁling
identiﬁed two additional serine phosphorylation sites
of rat NKCC2, S126, and S874, both showing dDAVP-
dependent phosphorylation in a protein kinase A-dependent
manner.18
Multiple phosphorylation sites have been identiﬁed in
NCC including residues T53, T58, and S71 (rodent
nomenclature), and all three phosphorylation sites were
shown to be phosphorylated by dDAVP stimulation in
rats.19,20
Based on our prior studies, as previously discussed,4,5 in
addition to in situ hybridization studies on the relative
expression of AC6 mRNA in the kidney,21,22 we tested the
hypothesis that AC6 contributes to NKCC2 and NCC
expression and phosphorylation under both basal conditions
and after V2R stimulation. We examined mice that lack AC6
(AC6/) to gain further insights. The results indicate an
important contribution of AC6 for basal NKCC2 and NCC
expression, as well as dDAVP-induced NKCC2 and NCC
phosphorylation and expression. Moreover, mice lacking
AC6 show features of Bartter syndrome.
Materials and Methods
Animals
All animal experimentation was conducted in accordance
with the Guide for Care and Use of Laboratory Animals
(National Institutes of Health, Bethesda, MD) and was
approved by the local Institutional Animal Care and
Use Committee. Age-matched, 3-month-old to 6-month-
old male and female AC6/ and wild-type (WT) litter-
mates were generated, as described,23 using heterozygousThe American Journal of Pathology - ajp.amjpathol.orgbreeding. Their genetic background is a mix of 129Sv/J
and C57BL/6, both sexes were used for experiments.
Mice with free access to food and water were euthanized
and kidneys removed. Kidneys were prepared for Western
blotting and immunohistochemistry (see as follows for
details).Role of AC6 for dDAVP-Stimulated NKCC2 and NCC
Expression and Phosphorylation
To study acute effects of dDAVP on NKCC2 and NCC
expression and phosphorylation, short-term water loading
(3% of body weight by oral gavage4) was performed
followed by application of vehicle (sterile water, 2 mL/g
body weight i.p.) or dDAVP (0.1 mg/kg i.p., Sigma-Aldrich,
St. Louis, MO). This dose of dDAVP prevents water-load
induced diuresis in WT mice24 and induces a comparable
urine osmolality observed after 18-hour water restriction.4
One hour after injection, mice were euthanized and kidneys
were prepared for immunohistochemistry and confocal laser
scanning microscopy, described as follows.
To more strongly suppress endogenous vasopressin
levels, mice were provided with 5% dextrose/1% ethanol
solution overnight.4,17 The next day, mice were injected
with vehicle (sterile water, 2 mL/g body weight i.p.) or
dDAVP (0.1 mg/kg i.p., Sigma-Aldrich) and euthanized 20
minutes after injection. Kidneys were prepared for Western
blotting, described as follows.Western Blot Analyses
Renal tissue was homogenized in buffer containing
protease inhibitor cocktail (250 mmol/L sucrose, 10 mmol/
L triethanolamine, Sigma-Aldrich; Roche Applied Science,
Indianapolis, IN, respectively) and Halt phosphatase
inhibitor cocktail (Thermo Fisher Scientiﬁc, Waltham,
MA). The homogenate was centrifuged at 4000 g for 15
minutes. Pellets were resuspended and used for Western
blotting. Equal lane loading (total NKCC: 30 mg, pS126
NKCC2: 30 mg, total NCC: 20 mg, and pT58 NCC: 20 mg)
was achieved using a Bio-Rad DC Protein assay (Bio-Rad
Laboratories, Richmond, CA). Samples were resolved on
4% to 12% NuPAGE gels in MOPS buffer (Invitrogen,
Carlsbad, CA). Gel proteins were transferred to nitrocel-
lulose membranes and immunoblotted with antibodies
against NKCC2 (dilution 1:20,000, generous gift from Jan
Lofﬁng, University of Zurich),25 pS126 NKCC2 (1:1000)
(generous gift from Chung-Lin Chou and Mark Knepper,
NIH),18 NCC (1:2000, Millipore, Billerica, MA),26 and
pT58-NCC (1:200, provided by Shinichi Uchida).27,28
Chemiluminescent detection was performed with ECL
(Amersham, Piscataway, NJ). Densitometric analysis was
performed by using ImageJ Software v1.46 (NIH,
Bethesda, MD). ß-actin was used as a loading control
(dilution 1:5000, Sigma-Aldrich).97
Rieg et alImmunofluorescent Labeling of Kidney Sections,
Confocal Laser Scanning Microscopy, and Image
Quantification
Tissue preparation, sectioning, and labeling were performed
as previously described.29 Primary antibodies used were
against NCC (1:4000), pT58 NCC (1:70,000), total NKCC2
(1:100), and pS126 NKCC2 (1:2000). Goat anti-rabbit Alexa
488 conjugated secondary antibodies (Invitrogen) were used
for visualization of labeling. Sections were mounted using
glycerol-based mounting medium containing anti-fade
reagent (Dako, Carpinteria, CA). A Leica TCS SL confocal
microscope with an HCX PL APO 63 oil objective lens
(numerical aperture: 1.40) was used for imaging of labeled
sections (Leica Microsystems, Ballerup, Denmark). For
the semiquantitative imaging, six individual images from
a labeled section per experimental mouse were acquired (30
images per genotype/experimental condition). Images were
obtained using identical microscope settings (PMT offset and
gain, sampling period, and averaging) for each tissue section
labeled with a speciﬁc antibody. The dynamic range of the
image acquisition was set so that the sections with the most
intense ﬂuorescence signal only had a few saturated pixels.
The digital images were analyzed using ImageJ v1.46 soft-
ware (NIH). Brieﬂy, threshold intensity was set per image to
highlight the speciﬁc labeling of an individual tubule with
negligible background. This image was converted to binary
and background noise (speckles) removed. The integrated
density of this image was obtained, providing a measurement
of the total image area with speciﬁc labeling signal. As the
length of labeled tubule varies between images, the binary
image was also used to mask and then quantify the speciﬁc
labeling pixel intensity from the corresponding original raw
image. Using these values, the total integrated pixel intensity
of each image in relation to the total area of labeled DCT or
TAL was calculated, providing semiquantitative data of the
labeling intensity, and thus abundance of protein, per tubule.
This technique has been previously used with alternative
antibodies and control studies performed by using serial
sections and serial dilution of the primary antibody.30 The
apical-to-basolateral pixel distribution was assessed simi-
larly. Multiple regions of interest (ﬁve per labeled tubule, ﬁve
tubules per animal), representing 4-mm single cross-sections
through labeled DCT and mTAL cells, were selected, and
distribution of pixel intensities from the apical cell pole
through to the basolateral side was assessed using ImageJ
v1.46 software (NIH). Using the plot proﬁle function, the
total pixel intensities in the initial 0.5 mm (representing the
most apical NKCC2/NCC labeling) were analyzed by
calculating the area under the curve using GraphPad Prism v5
(La Jolla, CA).
Immunohistochemistry
All procedures have been previously described in detail.29
Labeling was visualized by use of a peroxidase-conjugated98secondary antibody for light microscopy (P448, Dako,
Glostrup, Denmark) and visualized with 0.05% 3,30-dia-
minobenzidine tetrachloride (Kemen Tek, Copenhagen,
Denmark). Light microscopy was performed with a Leica
DMRE (Leica Microsystems). All microscope and camera
settings were identical when obtaining images from
different experimental conditions.
Statistical Analysis
The data are expressed as means  SEM and analyzed using
SigmaPlot v11.0 (San Jose, CA) software. Unpaired
Student’s t-test and the analysis of variance, followed by the
Bonferroni post test were performed, as appropriate, to
analyze statistical differences between the groups with P <
0.05 considered to be statistically signiﬁcant.
Results
NKCC2 Expression Is Decreased in AC6/ Mice
Under basal conditions, Western blot analysis showed that
total renal NKCC2 expression wasw50% lower in AC6/
versus WT mice (Figure 1A). This was associated with
a w1.8-fold greater expression of pS126 NKCC2 in
AC6/ compared to WT mice (Figure 1B). Qualitative
immunohistochemistry after short-term water loading
(control for dDAVP), to suppress endogenous AVP levels,
did not change the cellular localization of NKCC2
(Figure 2). By using immunoﬂuorescence labeling and
confocal analysis with identical conditions, however, we
conﬁrmed a reduced total of NKCC2 staining in kidneys of
AC6/ mice compared to WT in both mTAL and cTAL
(Figure 3). The abundance of NKCC2 phosphorylated at
S126 was low in mTAL of WT mice and not detectable in
AC6/ mice. In comparison, no apparent differences were
observed in labeling intensity of the cTAL between
genotypes, which had overall greater labeling intensity
than the mTAL (Figure 4). Quantiﬁcation of pS126
NKCC2 conﬁrmed signiﬁcantly lower abundance in mTAL
of AC6/ versus WT mice (Figure 5, A and B); again, no
differences were observed in labeling intensity of cTAL
between genotypes (Figure 5, A and C). The short-term
water loading may have reduced pS126 NKCC2 to
a greater extent in AC6/ mice, which could explain why
renal pS126 NKCC2 expression was only higher in these
mice in the Western blot analysis performed under basal
conditions.
Blood sample analysis revealed lower plasma Kþ
concentrations (AC6/: 4.3  0.1 mmol/L; WT: 4.7  0.1
mmol/L, nZ 9-10/genotype; P < 0.05) and a higher plasma
pH (AC6/: 7.443  0.004; WT: 7.419  0.009,
n Z 9e10/genotypes; P < 0.05) in AC6/ mice, both
pathognomonical ﬁndings in Bartter syndrome, consistent
with the lower total NKCC2 expression and membrane
labeling on the whole kidney level.ajp.amjpathol.org - The American Journal of Pathology
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Figure 1 Total Na-K-2Cl cotransporter 2 (NKCC2)
expression is decreased in mice lacking AC6, and water
loading (WL) overnight unmasks dDAVP effects on renal
membrane expression of total NKCC2 and NKCC2 phosphory-
lated at serine 126 (pS126 NKCC2). A: Renal protein
expression of NKCC2 was significantly lower in AC6/
compared to wild-type (WT) mice under basal conditions.
This was associated with enhanced phosphorylated serine
126 NKCC2 (pS126 NKCC2) expression in AC6/ versus WT
(n Z 3/group). B: Compared with regular fluid intake, WL
suppressed total NKCC2 expression, and the expression
remained higher in AC6/ versus WT mice. Treatment with
dDAVP increased total renal expression of NKCC2 to compa-
rable levels in both genotypes. The dDAVP-induced increase
in renal pS126 NKCC2 observed in WT, however, was lacking in
AC6/ mice (n Z 2 and n Z 4/group) for WL and dDAVP
treatments, respectively. *P < 0.05 versus WT, yP < 0.05
versus control same genotype.
The Role of AC6 in NKCC2/NCC RegulationdDAVP-Induced mTAL Phosphorylation of S126 NKCC2
Is Absent in AC6/ Mice
Quantitative laser-scanning confocal microscopy indicated
that dDAVP treatment after short-term water loading did not
change the labeling intensity for total NKCC2 in mTAL and
cTAL of either group (Figure 3). In comparison, labeling of
pS126 NKCC2 signiﬁcantly increased in the mTAL of WT
mice in response to dDAVP treatment (Figure 5). This
response was absent in AC6/ mice. dDAVP did not affect
labeling intensity of pS126 NKCC2 in cTAL of WT or
AC6/ mice (Figure 5). The signal intensity of total
NKCC2 labeling in the mTAL was greater in the ﬁrst 500
nm of the apical plasma membrane domain in dDAVP-
treated WT compared to AC6/ mice (Figure 6).Figure 2 Reduced total Na-K-2Cl cotransporter 2 (NKCC2) labeling in
medullary mTAL and cortical thick ascending limb cTAL of AC6/
knockout mice. Diaminobenzidine stained panels show representative
images of kidney sections from wild-type (WT) and AC6/ under control
(acute water loading) or dDAVP-treated conditions. Original magnification:
4 (insets).
The American Journal of Pathology - ajp.amjpathol.orgOvernight Suppression of Endogenous Vasopressin
Reveals a Role of AC6 for the dDAVP-Induced Increase
in pS126 NKCC2 and Total NKCC2
In another set of mice, we performedWestern blot analyses to
assess the expression and phosphorylation of total NKCC2
and pS126NKCC2 in response to dDAVP after water loading
overnight. Compared with regular ﬂuid intake (Figure 1A),
water loading overnight (control) appeared to suppress total
NKCC2 expression, and the expression remained higher in
AC6/ versus WT mice (Figure 1B). Treatment with
dDAVP increased total renal expression of NKCC2 to
comparable levels in both genotypes (Figure 1B). Of note,
dDAVP treatment increased total renal NKCC2 expression
in WT by 13  3-fold, but only by 1.9 0.3-fold in AC6/
mice. The abundance ofpS126NKCC2wasnot different under
control conditions between genotypes. The dDAVP-induced
increase, however, in renal pS126 NKCC2 observed in WT
was lacking in AC6/ mice (Figure 1B).NCC Expression, But Not T58 Phosphorylation, Is
Increased in AC6/ Mice
Western blot analyses under basal conditions revealed that
NCC was readily detectable as monomers, as well as poly-
mers (Figure 7A). The latter were proposed to be of functional
importance.31 Bartter syndrome is typically associated with
an increased NCC expression.25,32 This is possibly a conse-
quence of a reduced NKCC2 expression/activity and a greater
delivery of NaCl from the TAL or secondary to renal NaCl
loss.We found that total renal NCC expressionwasw1.9 fold
greater in AC6/ versus WT mice; however, expression of99
mTAL
NKCC2
cTAL
NKCC2
control control+dDAVP +dDAVP
AC6
-/- WT
N
or
m
al
iz
ed
 fl
uo
re
sc
en
t i
nt
en
sit
y
re
la
tiv
e 
to
 W
T 
co
nt
ro
l (A
U)
0.0
0.5
1.0
1.5
2.0 control
+dDAVP
control
+dDAVP
*
*
N
or
m
al
iz
ed
 fl
uo
re
sc
en
t i
nt
en
sit
y
re
la
tiv
e 
to
 W
T 
co
nt
ro
l (A
U)
0.0
0.5
1.0
1.5
2.0
*
WT AC6-/-
WT AC6-/-
Figure 3 Quantitative laser-scanning confocal microscopy indicates reduced total NKCC2 labeling in medullary mTAL and cTAL of AC6/ mice. A: Panels
show representative images of kidney sections from wild-type (WT) and AC6/ mice under control (acute water loading) or dDAVP-treated conditions
(Images have been digitally altered to improve brightness/contrast for publication purposes). B: Labeling intensity of NKCC2 in mTAL is significantly lower in
AC6/ compared to WT control. dDAVP had no effect on labeling intensity in either genotype. C: Labeling intensity of NKCC2 in cTAL is significantly lower in
AC6/ compared to WT control. dDAVP had no significant effect in either genotype. Scale-bar, mTAL, 10 mm; cTAL, 25 mm. *P < 0.05 versus WT.
Figure 4 dDAVP-induced increases in NKCC2 phosphorylated at serine 126
(pS126 NKCC2) in mTAL is absent in AC6/ mice. Diaminobenzidine stained
panels show representative images of kidney sections from wild-type (WT) and
AC6/ under control (acute water loading) or dDAVP-treated conditions.
pS126 NKCC2 labeling is reduced in mTAL in AC6/ mice compared to WT
control, but there is no apparent difference in labeling intensity of the cortical
thick ascending limbbetweengenotypes, which overall wasmuch stronger than
the medullary labeling. Labeling intensity increases in the mTAL in WT mice
after dDAVP, but dDAVPhasnoapparent effect onpS126NKCC2 levels inAC6/
mice or cortical thick ascending limb (cTAL) of either genotype. Original
magnification:4 (insets).
Rieg et alpT58 NCCwas not different between genotypes (Figure 7A).
Qualitative immunohistochemistry after short-term water
loading (control for dDAVP), did not change the cellular
localization of NCC (Figure 8). By using immunoﬂuores-
cence labeling and confocal analysis under identical condi-
tions, however, we conﬁrmed a more intense staining of total
NCC in AC6/ versus WT mice in the DCT (Figure 9A and
B), and that labeling of pT58 NCC was comparable between
genotypes (Figure 9A and C).
dDAVP-Induced Phosphorylation of T58 NCC Is Absent
in AC6/ Mice
Qualitative immunohistochemistry and quantitative laser-
scanning confocal microscopy indicated that dDAVP treat-
ment after short-term water loading did not change the
labeling intensity for total NCC in DCT of either group
(Figure 8 and Figure 9, A and B). Labeling of pT58 NCC
signiﬁcantly increased in response to dDAVP in WT, but not
in AC6/mice (Figure 8 and Figure 9, A and C). Total NCC
labeling after dDAVP treatment in the DCT showed no
difference in signal intensity and distribution in the region of
the apical plasma membrane between genotypes (Figure 10).
Overnight Suppression of Endogenous Vasopressin
Reveals a Role of AC6 for the dDAVP-Induced Increase
in pT58 NCC and Total NCC
As observed under basal conditions and after short-term
water loading (see previously), total NCC expression was100signiﬁcantly higher in AC6/ versus WT after water-
loading overnight (control); dDAVP treatment signiﬁ-
cantly increased total renal NCC expression in WT with
these conditions (Figure 7B). This effect was reversed in
AC6/, with dDAVP decreasing total renal NCC expres-
sion (Figure 7B). After water-loading overnight, renal pT58
NCC expression was higher in AC6/ versus WT;
however, as observed after short-term water loading, treat-
ment with dDAVP increased renal pT58 NCC expression
only in WT with these conditions (Figure 7B).ajp.amjpathol.org - The American Journal of Pathology
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Figure 5 Quantitative laser-scanning confocal microscopy indicates absence of NKCC2 phosphorylation in response to dDAVP at serine 126 (pS126 NKCC2) in
medullary thick ascending limb (mTAL) of AC6/mice (A). Panels show representative images of kidney sections fromwild-type (WT) andAC6/mice under control
(acutewater loading) or dDAVP-treated conditions (Imageshave beendigitally altered to improvebrightness/contrast for publication purposes).B: Labeling intensity
of pS126 NKCC2 in mTAL is significantly lower in AC6/ compared to WT control. dDAVP significantly increases pS126 NKCC2 in WT, but not AC6/ mice. C: No
significant differences were observed in labeling intensity of pS126 NKCC2 in cortical TAL between the groups, and dDAVP had no significant effect in either genotype.
Scale-bar, mTAL, 10 mm; cTAL, 25 mm. *P < 0.05 versus WT, yP < 0.05 versus control same genotype. AU, signal intensity; cTAL, cortical thick ascending limb.
The Role of AC6 in NKCC2/NCC RegulationDiscussion
For the ﬁrst time, the present studies show that AC6 is
a determinant of basal expression of NKCC2 and NCC, as
well as dDAVP-stimulated phosphorylation of S126
NKCC2 and T58 NCC in the mouse kidney. To ourThe American Journal of Pathology - ajp.amjpathol.orgknowledge, this is the ﬁrst time showing the functionality of
both phospho-speciﬁc antibodies in the mouse. With regard
to NKCC2 phosphorylation, the stimulatory effect of
dDAVP and the role of AC6 seem to be restricted to the
medullary segment of the TAL. At the latter site, dDAVP-
induced phosphorylation of NKCC2 in WT mice wasFigure 6 Greater membrane signal intensity of
NKCC2 in the first 500 nm of medullary thick
ascending limb (mTAL) in wild-type compared to
AC6/ mice after dDAVP treatment. A: Panels
show representative images, analyzed by quanti-
tative laser scanning microscopy of kidney sections
from wild-type (WT) and AC6/ mice after short-
term water loading followed by dDAVP treatment.
Colored lines represent regions of interest exam-
ined for NKCC2 labeling distribution in lower panels
(Images have been digitally altered to improve
brightness/contrast for publication purposes). B:
Distribution of NKCC2 labeling. Signal intensity
(AU) is measured from the apical pole of the cell
with each trace representing an alternative cell.
The mean amplitude of signal intensity is greater in
the first 500 nm of WT mice, indicating greater
NKCC2 labeling of the apical plasma membrane.
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Figure 7 Total Na-Cl cotransporter (NCC) expression is
increased in mice lacking AC6, and water loading overnight
(WL) unmasks dDAVP effects on renal membrane expression
of NCC and NCC phosphorylated at threonine 58 (pT58 NCC).
A: Renal protein expression of NCC was significantly higher in
AC6/ compared to wild-type (WT) mice under basal
conditions. Renal expression of phosphorylated threonine 58
NCC (pT58 NCC) was not significantly different between
genotypes (n Z 3/group). B: Total NCC expression was
significantly higher in AC6/ versus WT after WL and dDAVP
treatment significantly increased total renal NCC expression
in WT under these conditions. This effect was reversed in
AC6/ mice. After WL renal pT58 NCC expression was higher
in AC6/ versus WT; however, treatment with dDAVP
increased renal pT58 NCC expression only in WT (n Z 2 and
n Z 4/group) for WL and dDAVP treatment, respectively.
*P < 0.05 versus WT, yP < 0.05 versus control same
genotype.
Figure 8 Absent NCC phosphorylation in response to dDAVP at thre-
onine 58 (pT58 NCC) in the distal convoluted tubule of AC6 knockout mice.
Diaminobenzidine stained panels show representative images of cortical
kidney sections from wild-type (WT) and AC6/ mice under control (acute
water loading) and dDAVP-treated conditions. Original magnification: 4
(insets).
Rieg et alassociated with a greater signal intensity for NKCC2 in the
outermost 500 nm of the luminal membrane compared with
mice lacking AC6.
We have previously shown that AC6 determines cAMP
formation and aquaporin 2 phosphorylation and trafﬁcking
in the inner medullary collecting duct, and that mice lacking
AC6/ suffer from nephrogenic diabetes insipidus.4 The
role of AC6, however, in the expression and function of
other renal transporters, including NKCC2 and NCC, has
not been studied. Knockout of NKCC232 or a tubulus-
speciﬁc knockdown of a kinase that regulates its function,
oxidative stress-responsive kinase-1, causes Bartter
syndrome.33 We found that basal renal NKCC2 expression
is signiﬁcantly lower in AC6/ mice. The increased total
renal abundance of pS126 NKCC2 in AC6/ mice may
protect the mouse from developing a more severe salt-losing
phenotype. The increased pS126 NKCC2, however, was
not seen in our immunohistochemical studies or with
semiquantitative laser scanning microscopy after short-term
water loading, which might have suppressed S126 NKCC2
phosphorylation to a greater extent in AC6/ mice. Our
data are the ﬁrst to show in the mouse kidney that AVP
increases pS126 NKCC2 abundance, conﬁrming previous
data in the rat.18 The molecular mechanism increasing
pS126 NKCC2 abundance in AC6/ mice under basal
conditions remains unknown, but the ﬁndings indicate an
AC6-independent mechanism of NKCC2 phosphorylation.
Another common ﬁnding in Bartter syndrome is an102increased expression of NCC, as well as hypotension.25,33,34
Consistent with these ﬁndings, AC6/ mice have higher
renal NCC expression and membrane NCC labeling (current
study), and a lower blood pressure.35 We previously found
a tendency for higher urinary Naþ excretion in AC6/
mice,4 an effect that may be due to reduced transport in the
TAL and might have been dampened by a lower blood
pressure, and therefore reduced pressure natriuresis. Also,
urinary Kþ excretion was higher in AC6/ mice.4 Overall,
AC6 deﬁciency causes only a mild salt-losing phenotype
compared with the massive salt-losing nephropathyajp.amjpathol.org - The American Journal of Pathology
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Figure 9 Quantitative laser-scanning confocal microscopy identifies greater total NCC labeling in AC6/ mice, but the phosphorylation response to
dDAVP at threonine 58 (pT58 NCC) is absent. A: Panels show representative images of cortical kidney sections from wild-type (WT) and AC6/ mice under
control (acute water loading), or dDAVP treated conditions. B: Total NCC labeling intensity is significantly greater in AC6/ compared to WT control, but no
effects of dDAVP were observed in either group. C: Basal labeling intensity of pT58 NCC is not significantly different between the groups. dDAVP significantly
increases pT58 NCC labeling in WT, but not AC6/ mice. Scale-bar, 25 mm. *P < 0.05 versus WT, yP < 0.05 versus control same genotype. AU, signal
intensity.
The Role of AC6 in NKCC2/NCC Regulationobserved in mice with inactivation of all NKCC2
isoforms.32
Does AC6 contribute to dDAVP-stimulated NKCC2
phosphorylation and membrane expression? We observed
a dDAVP-induced increase of total renal NKCC2 expression,
as well as S126 NKCC2 phosphorylation inWTmice, effectsThe American Journal of Pathology - ajp.amjpathol.orgthat were reduced in AC6/ mice. The observed effect of
dDAVP-induced increase in total NKCC2 expression was
only detected after water-loading overnight, which is ex-
pected to strongly suppress plasma AVP and maybe as
a consequence, NKCC2 expression. Thus, the experimental
condition might have enabled us to unmask such a response.Figure 10 Comparable membrane distribution
of total NCC in the distal convoluted tubule between
wild-type (WT) and AC6/ mice after dDAVP
treatment. A: Panels show representative images,
analyzed by quantitative laser scanning micros-
copy, of kidney sections from WT and AC6/ mice
after short-term water loading followed by dDAVP
treatment. Colored lines represent regions of
interest examined for NCC labeling distribution in
lower panels. B: Distribution of NCC labeling. Signal
intensity (AU) is measured from the apical pole of
the cell with each trace representing an alternative
cell. The mean amplitude of signal intensity is not
different between genotypes, indicating a compa-
rable amount of NCC at the apical plasmamembrane.
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Rieg et alImmunohistochemistry and immunoﬂuorescence conﬁrmed
the defect in dDAVP-induced phosphorylation of S126
NKCC2 inAC6/mice; of note, this effect of dDAVP inWT
and the defect inAC6/micewere only present in themTAL
and not in the cTAL. The role of vasopressin in NKCC2
phosphorylation and translocation was shown by Gimenez
and Forbush17 and conﬁrmed by others.36e38 There is now an
accumulating body of evidence that NKCC2 activation by the
V2R involves cAMP-stimulation of protein kinase A.
38 Our
data expand this knowledge and add AC6 in the mTAL as
a key enzyme in this signaling pathway. Giminez and For-
bush,17 by using electron microscopy, showed that 5% to 6%
of total NKCC2 immunolabeling is found within 70 nm from
the apical membrane, and 45% of total NKCC2 is located
within the ﬁrst 140 nm. In the mTAL, we observed a shift of
NKCC2 toward the tubule lumen in dDAVP-stimulated WT
compared with AC6/mice. This might reﬂect an important
role of AC6 in the regulation and phosphorylation of transport
proteins in cell membrane microdomains (eg, lipid rafts/
caveolae) in a manner akin to what has been noted for aqua-
porin-2,4 and/or is related to proposed actions of snapin,39
which controls protein kinase A-stimulated, and soluble N-
ethylmaleimide-sensitive factor attachment protein receptor-
mediated NKCC2 exocytosis.40
The role of AC6 in dDAVP-induced regulation of total
renal NKCC2 expression and phosphorylation at S126
appears to be restricted to the medullary portion of the TAL.
Of note, we previously found a similar pattern for dDAVP-
induced phosphorylation and regulation of aquaporin-2
along the collecting duct.4 In the medulla, AC6 is required
for full phosphorylation of aquaporin-2 at S256 and S269.
In contrast, phosphorylation of aquaporin-2 was unaffected
in the renal cortex of AC6/ mice.4 These ﬁndings are
consistent with the concept that speciﬁc AC isoforms
mediate nephron segment-speciﬁc hormonal effects.
AC6 is also involved in the signaling cascade of AVP-
induced phosphorylation of NCC. Previous studies indi-
cated that the expression of NCC phosphorylated at residue
T58 is restricted to the apical plasma membrane; electron
microscopy studies showed weak labeling of pT58 NCC in
AVP-deﬁcient Brattleboro rats and dDAVP treatment
increased the abundance of pT58 NCC only in the apical
membrane.19 Our studies indicate that AC6 is not critical for
the basal phosphorylation of NCC at T58 or NCC
membrane expression. In fact, we ﬁnd a higher, possible
compensatory increase in total NCC and, in addition, in
pT58 NCC after water-loading overnight. The dDAVP-
induced increase in renal pT58 NCC abundance and
membrane staining in the DCT, however, was completely
absent in AC6/ mice, and thus required AC6. The
signaling pathway involved in vasopressin-induced NCC
phosphorylation is not known, but in addition to AC6,
might involve the “with-no-K[Lys] kinases”/STE20/SPS1-
related proline/alanine-rich kinase/oxidative stress-
responsive kinase-1 pathway.19 The dDAVP-induced
increase in total renal NCC expression, which was only104observed in WT mice after water-loading overnight, was
also dependent on AC6. A previous study reported an
increase in renal NCC expression after chronic dDAVP
administration.14
In contrast to a proposed effect on the trafﬁcking of
NKCC2 and aquaporin 2, the effect of dDAVP-induced
phosphorylation on NCC trafﬁcking remains unclear; it may
rather be required for full intrinsic NCC activity. Western
blotting and immunogold labeling indicated unchanged
membrane NCC expression and no trafﬁcking in response to
dDAVP administration when stimulated for 60 minutes.20
Another study found that a 30-minute dDAVP administra-
tion increased plasma membrane NCC, as determined by
confocal microscopy, immunogold labeling, and Western
blotting, possibly indicating increased apical trafﬁcking of
the transporter,20 although an increased membrane retention
may also have contributed. Both studies used Brattleboro
rats, and the reason for these different ﬁndings remained
elusive but might relate to differences in the time course.
We could not detect an increase in membrane signaling
intensity of total NCC in response to dDAVP after
short-term water loading in WT mice when analyzed by
immunohistochemistry or confocal immunoﬂuorescence
microscopy. Further studies are needed to better understand
the regulation and trafﬁcking of NCC.
In summary, the current results demonstrate that AC6
mediates vasopressin-induced phosphorylation of NKCC2
at S126 and of NCC at T58 in the kidney. AC6 is also
a stimulator of renal NKCC2 protein abundance in mTAL
and cTAL. As a consequence, mice lacking AC6 have lower
NKCC2 expression and present with a mild Bartter
syndrome-like phenotype, including lower plasma concen-
trations of Kþ and Hþ and upregulation of downstream
NCC expression. In addition to the latter, increased
AC6-independent phosphorylation of NKCC2 at S126
might help to compensate in the absence of AC6.
Vasopressin-induced NKCC2 phosphorylation at S126 and
the role of AC6 herein were restricted to the medullary
portion of the TAL. The segment-speciﬁc use of different
AC isoforms might increase the regulatory versatility of
hormone-induced signaling along the nephron.Acknowledgments
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